Rapid uptitration of oral treatment for heart failure (HF) is safe, according to researchers, who found this approach results in a reduction in the composite of death or HF rehospitalization at 180 days and improvements to patient quality of life regardless of the patients’ left ventricular ejection fraction (LVEF) level.